An Open-label Trial of Alpha-lipoic Acid/L-acetyl Carnitine for Progressive Supranuclear Palsy (PSP): Effect Upon Oxidative Damage and Mitochondrial Biomarkers.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Biotin/levacecarnine/thioctic acid (Primary)
- Indications Progressive supranuclear palsy
- Focus Adverse reactions; Biomarker
- 30 May 2017 Biomarkers information updated
- 05 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 03 Mar 2012 New trial record